Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations
Anni Winckelmann, Kirston Barton, Bonnie Hiener, Timothy E Schlub, Wei Shao, Thomas A Rasmussen, Lars Ostergaard, Ole S Sogaard, Martin Tolstrup, Sarah Palmer
AIDS | LIPPINCOTT WILLIAMS & WILKINS | Published : 2017
Awarded by Delaney AIDS Research Enterprise (DARE)
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by Danish Council for Strategic Research
Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
This work was supported by the Delaney AIDS Research Enterprise (DARE) to Find a Cure 1U19AI096109 and the National Health and Medical Research Council (NHMRC) of Australia (grant APP1061681). The clinical study from which these samples were derived was sponsored by Bionor Pharma.T.A.R., L.O., M.T. and O.S.S. were supported by a grant from the Danish Council for Strategic Research (grant # 0603-00521B). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Bionor Pharma contributed to the design of the clinical trial.